Skip to main content
FinSpry Logo
FinSpry
RGC logo
RGC
(NASDAQ)
Regencell Bioscience Holdings Limited
$30.80-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Regencell Bioscience Holdings (RGC) Stock Price & Financial Analysis

Regencell Bioscience Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.50 - $37.99
52-Week High$83.60
52-Week Low$0.58
Open$32.06
Volume327.69K
Average Volume (3M)327.69K
Market Cap15.23B
Shares Outstanding494.49M
P/E Ratio (TTM)658.68
Price to Book (P/B)3430.70
EV/EBITDA-2427.03
50-Day MA$26.91
200-Day MA$20.40
52-Week Change4319.98%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Regencell Bioscience Holdings

What is the current stock price for RGC?

As of the latest trading session, RGC stock trades at $30.80. The 52-week range is $0.58–$83.60, with a day range of $29.50–$37.99.

What is the P/E ratio for RGC?

Regencell Bioscience Holdings's trailing P/E ratio is 658.7, meaning investors pay $658.7 for every $1 of annual earnings. Regencell Bioscience Holdings operates in the Healthcare sector.

Does RGC pay dividends?

Regencell Bioscience Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGC?

Analyst ratings and recommendations for RGC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of RGC?

Regencell Bioscience Holdings's market capitalization is $15.23B, classifying it as a large-cap company. Regencell Bioscience Holdings operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.